News from decision resources group A wide array of domestic and global news stories; news topics include politics/government, business, technology, religion, sports/entertainment, science/nature, and health/lifestyle.

Latest

Oct 24, 2016, 08:32 ET Decision Resources Group Expands Global Consulting Services to Asia Pacific

Decision Resources Group (DRG) announced today that it has expanded into Asia Pacific (APAC) with the establishment of a local consulting office in...


Oct 24, 2016, 08:32 ET The Launch of Merck's Letermovir for Cytomegalovirus Will Transform the Treatment Paradigm for Transplant Recipients, While the Availability of a New Prophylactic Vaccine and Antibody Will Drive Growth in the Respiratory Syncytial Virus Market

Decision Resources Group finds that the number of treatment-eligible patients in the Cytomegalovirus (CMV) and Respiratory Syncytial Virus (RSV)...


Oct 11, 2016, 09:05 ET Decision Resources Group Leads Series B Investment In Context Matters

Context Matters, Inc., the leading provider of health economics data for pharmaceutical industry market access intelligence, and Decision Resources...


Oct 05, 2016, 08:30 ET Identification of new patient populations using validated companion diagnostic tests is a valuable strategy to help ensure payer acceptance of new premium priced targeted therapies and guide oncologists' treatment decisions.

Decision Resources Group finds that biomarker-targeted therapies with companion diagnostic tests are viewed positively by both oncologists and payers ...


Oct 03, 2016, 08:30 ET More Than Half of Surveyed U.S. and European Psychiatrists Report High Unmet Need for an Efficacious Therapy for Cognitive Impairment Associated with Schizophrenia

Decision Resources Group finds that, in a survey of U.S. and European psychiatrists, nearly all respondents indicate a moderate to high level of...


Sep 29, 2016, 08:30 ET Influx of TAF-Containing Fixed-Dose Combinations From Gilead and Janssen Will Address Patient Needs for Long-Term Safety and Replace Established Treatment Options in the HIV Market

Decision Resources Group finds that U.S. physicians and payers alike recognize the benefits provided by the new generation of highly effective, safer ...


Sep 28, 2016, 08:30 ET U.S. and European Physicians See a Continued Need for New Osteoporosis Therapies with Improved Safety and Tolerability, and the Potential to Increase Patient Compliance

Decision Resources Group finds that despite numerous available therapies for osteoporosis, there remains an opportunity for therapies that offer...


Sep 27, 2016, 09:00 ET First-in-Class Anti-CGRP Monoclonal Antibodies for Migraine Prevention from Eli Lilly, Teva, Amgen/Novartis, and Alder will Drive Market Growth Through 2025

Decision Resources Group finds that the overall migraine market will grow from approximately $3 billion in 2015 to over $10 billion in 2025 in the...


Sep 26, 2016, 08:30 ET Lower Costs To Payers And Institutions Are Key Drivers For Biosimilar Uptake

Decision Resources Group finds that prescribing of biosimilars is more widespread in France and Germany than in the United States, even though nearly ...


Sep 19, 2016, 08:30 ET Surveyed MCO Pharmacy and Medical Directors Report that the Market-Leading TNF-Alpha Inhibitors Enbrel and Humira Continue to Enjoy the Most Favorable Formulary Coverage in the United States

BURLINGTON, Mass., Sept. 19, 2016 /PRNewswire/-- Decision Resources Group finds that rheumatoid arthritis (RA) biologics and Xeljanz have widespread...


Sep 14, 2016, 08:30 ET How far to go in comparative assessments of health technologies?

Recent research conducted by DRG Abacus in collaboration with leading academics at Leicester University highlights the benefit of extending decision...


Aug 29, 2016, 09:00 ET The US Market for Enterprise Solutions Will Increasingly Favor VNA Over Traditional Enterprise PACS as the Market Nearly Triples in Size by 2025

Decision Resources Group finds that rapid hospital consolidation and the continued shift toward value-based health care have pushed enterprise IT...


Aug 23, 2016, 08:30 ET Trend Shifts Toward Outpatient Orthopedic Procedures

Decision Resources Group finds that in spite of a longstanding discrepancy between hospital and ASC (Ambulatory Surgical Center) reimbursement, the...


Jul 19, 2016, 08:09 ET Decision Resources Group Launches Intuitive New Platform to Access Real-Time Market Data

Decision Resources Group (DRG), a premier provider of high-value data, analytics and insights products and services to the healthcare industry, today ...


Jul 05, 2016, 11:00 ET The EU5 Market for Respiratory Drugs is Becoming Increasingly Crowded and Price-Sensitive

Decision Resources Group finds that access and reimbursement for both chronic obstructive pulmonary disease (COPD) and asthma are becoming...


Jun 30, 2016, 10:00 ET Few Surveyed U.S. and European Neurologists Report High Satisfaction with the Efficacy of Antiepileptic Drugs Approved or Commonly Prescribed to Treat Seizures Associated with Lennox-Gastaut Syndrome

Decision Resources Group finds that a majority of surveyed neurologists in the United States and Europe report only moderate satisfaction with the...


Jun 29, 2016, 09:00 ET Overall Uptake and High Prescribing Rate in Retreatment for Gilead's Harvoni Solidify Its Stronghold on the Hepatitis C Market

Decision Resources Group finds that despite increasing pressure from competitors, specifically AbbVie's Viekira Pak and Merck's Zepatier, Gilead's...


Jun 13, 2016, 10:00 ET U.S. and European Endocrinologists See a Continued Need for New Nonstatin Drugs with Cardiovascular Outcomes Benefits for Dyslipidemias

Decision Resources Group finds that despite the many therapies available, there is an ongoing need for drugs that improve LDL-C. Positive results...


Jun 09, 2016, 01:03 ET Decision Resources Group Analysts Highlight Key Trends Stemming from ASCO's 2016 Annual Meeting

Analysts from Decision Resources Groups' Oncology team share their insights and analysis on the key trends that were presented at the American...


Jun 07, 2016, 12:00 ET Decision Resources Group Study Finds Forty Three Percent of U.S. Physicians Struggle to Keep Up With Changing Healthcare System

Decision Resources Group finds that U.S. physicians are struggling to keep up with a fast-changing healthcare system. New goals reflect the shift...


Jun 01, 2016, 10:08 ET The Newly Launched IL-17 Inhibitor Cosentyx is Gradually Gaining Momentum in the EU5, While Established Subcutaneous TNF-Alpha Inhibitors Humira and Enbrel Continue to Dominate Biologics Patient Share in Psoriasis

Decision Resources Group finds that in the EU5, while surveyed dermatologists prefer subcutaneous TNF-alpha inhibitors AbbVie's Humira and...


May 24, 2016, 10:00 ET Decision Resources Group Cited in ACO Performance Benchmarking Study

Decision Resources Group (DRG) today announced that data from its market-leading database, Organized Customer Group Navigator (OCGN), was cited in an ...


Apr 19, 2016, 09:00 ET Decision Resources Group Launches Real World Evidence With Coverage of 90% of U.S. Healthcare System

Decision Resources Group (DRG) today announced that it has launched a Real World Evidence (RWE) repository of claims and EHR data that provides...


Apr 13, 2016, 09:12 ET Decision Resources Group Appoints Jonathan Sandler as Chief Executive Officer

Decision Resources Group (DRG), a subsidiary of India-based Piramal Enterprises Limited (Piramal), today announced that its Board of Directors has...


Mar 14, 2016, 09:45 ET Decision Resources Group Expands Product Sales in Latin America through Strategic Alliance with Close-Up International

Decision Resources Group (DRG) today announced that it has formed a strategic alliance with Close-Up International (CUI), a global leader in...